Submit Your Feeds

Business News • PR NewsWire • Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer

Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer

RARITAN, N.J., Oct. 11 /PRNewswire/ -- Results from a pre-specified interim analysis of a randomized, placebo-controlled Phase 3 study, COU-AA-301, demonstrate that patients treated with the investigational agent abiraterone acetate plus low-dose prednisone/prednisolone showed a significant improvem

View More : http://www.prnewswire.com/news-releases/abiraterone-acetate-significantly-improved-overall-survival-for-patients-with-me...
Releted News by prnewswire
Sonic Foundry, EDUCAUSE Partner to Create the Largest Hybrid Conference in EDUCAUSE History
Evatronix Receives USB-IF Certification for its SuperSpeed USB 3.0 Device IP Core
Tsipi Kagan Joins Ceragon Networks as Chief Financial Officer
Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
Apache Promotes Janine McArdle to Senior Vice President - Gas Monetization
Home Sitemap Contact Us
© businessNewsNewsNews.com